Condition (MeSH)
Rotavirus Infections
ClinicalTrials.gov lists 102 trials for Rotavirus Infections or a narrower condition beneath it. GlaxoSmithKline has the most among industry and government lead sponsors, with 61.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
102 of the 102 trials are tagged with Rotavirus Infections itself; the rest are tagged with a narrower condition beneath it.
When did Rotavirus Infections trials start? (25)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 13
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2025 | 2 |
| 2024 | 1 |
| 2023 | 2 |
| 2022 | 1 |
| 2020 | 1 |
| 2019 | 2 |
| 2018 | 4 |
| 2017 | 3 |
| 2016 | 2 |
| 2015 | 4 |
Showing 10 of 25 earlier years.
No forecast is made for this condition: it averages 1.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Rotavirus Infections trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 9 |
| Phase 1/2 | 1 |
| Phase 2 | 15 |
| Phase 2/3 | 1 |
| Phase 3 | 32 |
| Phase 4 | 6 |
| Not applicable | 4 |
| Observational | 34 |
How many Rotavirus Infections trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Active, not recruiting | 2 |
| Completed | 87 |
| Terminated | 2 |
| Withdrawn | 3 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Rotavirus Infections trials? (7)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| GlaxoSmithKline | 61 |
| Merck Sharp & Dohme LLC | 9 |
| Centers for Disease Control and Prevention | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Romark Laboratories L.C. | 2 |
Showing 5 of 7 sponsors.
Which drugs are being tested for Rotavirus Infections? (1)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Nitazoxanide | 3 |
Interventions as named in the registry (14)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Rotarix TM | 25 |
| data collection | 9 |
| RotaTeq | 6 |
| Rotavirus | 5 |
| Rotavirus (Bio Farma) Vaccine | 3 |
Showing 5 of 14 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Rotavirus Infections trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Gastroenteritis | 715 | 22 |
| Bronchiolitis | 710 | 20 |
| Pneumonia | 504 | 20 |
| Bronchopneumonia | 308 | 11 |
| Bronchitis | 255 | 12 |
Showing 5 of 10 adverse events.
Which publications cover Rotavirus Infections? (220)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Safety, immunogenicity, and relative efficacy of a parenteral trivalent rotavirus subunit vaccine candidate (TV P2-VP8) in healthy Ghanaian, Malawian, and Zambian infants. | Vaccine | 2026 | Yes |
| Success from the South: the rotavirus vaccine story and its lessons. | Lancet (London, England) | 2024 | Yes |
| Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in Mexican infants. | Frontiers in public health | 2024 | Yes |
| Differences in Rotavirus Shedding and Duration by Infant Oral Rotavirus Vaccination Status in Dhaka, Bangladesh, 2011-2014. | The Journal of infectious diseases | 2024 | Yes |
| Rotavirus-Specific Maternal Serum Antibodies and Vaccine Responses to RV3-BB Rotavirus Vaccine Administered in a Neonatal or Infant Schedule in Malawi. | Viruses | 2024 | Yes |
Showing 5 of 220 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.